Surgery for syringomyelia is generally safe when performed by board-certified neurosurgeons using micro-surgical decompression or duraplasty. While it effectively halts disease progression, major risks include cerebrospinal fluid leaks, infection, and localized nerve damage. Most procedures in JCI-accredited Turkish facilities proceed without life-threatening complications.
- Success objective: Surgery primarily aims to stop syrinx growth rather than reversing existing damage.
- Primary risks: Potential complications include meningitis, recurrence of the syrinx, or temporary neurological deficit.
- Advanced monitoring: Top clinics use intraoperative neuromonitoring to protect spinal cord function during surgery.
- Recovery timeline: Patients typically require 6–12 months for full recovery with scheduled follow-up MRIs.
Bookimed Expert Insight: Data from leading Istanbul centers like Anadolu Medical Center, which is affiliated with Johns Hopkins, shows a focus on treating the underlying cause—such as Chiari malformation—rather than just the syrinx. Neurological stability is the most realistic goal. Patients should prioritize surgeons like Prof. Dr. Ilhan Elmaci, who has over 110 publications, as experimental techniques are rarely safer than standard decompression for this specific condition.
Patient Consensus: Many patients report that while the syrinx shrinks on imaging, physical symptoms like numbness or nerve pain may persist or change. A slower, more cautious approach to physical therapy is often better tolerated than aggressive early rehabilitation.
